Patents by Inventor Jin Hee Im

Jin Hee Im has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250216091
    Abstract: Disclosed is a valve including a valve housing having an empty space therein, an opening/closing part provided in the valve housing and configured to be movable in an upward/downward direction H, a shaft part fixedly coupled to the opening/closing part and configured to be movable in the upward/downward direction H together with the opening/closing part, a drive part configured to move the shaft part in the upward/downward direction H, and a seating part protruding inward from an inner surface of the valve housing and configured to interfere with the opening/closing part when the opening/closing part moves in the upward/downward direction H by a predetermined distance.
    Type: Application
    Filed: October 18, 2024
    Publication date: July 3, 2025
    Applicant: KYUNGDONG NAVIEN CO., LTD.
    Inventors: Woo Hyung Cho, Min Jin Lee, Jin Hee Im, Doo Hyung Jeong
  • Publication number: 20230407292
    Abstract: The present invention relates to a monomeric streptavidin-expressing gene construct and a host cell into which a recombinant vector comprising the gene construct has been introduced. The gene construct according to the present invention, after injected in vivo through a strain, may express streptavidin, thereby making it possible not only to monitor in real time the location of the strain or a cancer tissue pre-targeted by the strain by using a biotinylated diagnostic agent, but also to increase the cancer targeting efficiency of a biotinylated anticancer agent.
    Type: Application
    Filed: October 29, 2021
    Publication date: December 21, 2023
    Inventors: Seong Young Kwon, Jung-Joon Min, Yeongjin Hong, Sung-Hwan You, Jin Hee Im
  • Publication number: 20230405131
    Abstract: The present invention relates to host cells expressing monomeric streptavidin. The host cells according to the present invention may express streptavidin in vivo, making it possible to visualize and monitor in real time the biodistribution of cancer tissue, pre-targeted by the host cell, with a biotinylated diagnostic agent, as well as to increase the cancer-targeting efficiency of biotinylated anticancer drugs.
    Type: Application
    Filed: October 29, 2021
    Publication date: December 21, 2023
    Inventors: Seong Young Kwon, Jung-Joon Min, Yeongjin Hong, Sung-Hwan You, Dong-Yeon Kim, Jin Hee IM
  • Publication number: 20120328721
    Abstract: The present invention relates to aloe vera sprout concentrate or extract having cell growth promotion, antioxidant, and anti-allergy effects, and to a skin cell growth promoting, antioxidant, and anti-allergy pharmaceutical composition and functional health food or cosmetics containing the aloe vera sprout concentrate or extract as an active ingredient.
    Type: Application
    Filed: November 16, 2010
    Publication date: December 27, 2012
    Applicants: Hilltop Gardens Inc.
    Inventors: Tae Hyung Jo, Seon Gil Do, Eun Ju Shin, Hye In Jang, Jin Wan Kim, Ghe Whan Ahn, Seung Won Yang, Jin Hee Im, Jeong Bum Nam, Soo Gyeom Kim, Ken Jones